Advanced Enzyme Technologies Ratios

Advanced Enzyme Technologies Ltd Ratios

The Advanced Enzyme Technologies Ltd Ratios page provides a complete fundamental analysis of Advanced Enzyme Technologies Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Advanced Enzyme Technologies Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Advanced Enzyme Technologies Ltd (NSE: ADVENZYMES, BSE: 540025) is currently trading at ₹294.90, with a market capitalization of ₹32.71B. As a major player in the Consumer non-durables sector and Food: specialty/candy industry, Advanced Enzyme Technologies Ltd remains a key stock for fundamental analysis using Advanced Enzyme Technologies Ltd Ratios.

Advanced Enzyme Technologies Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Advanced Enzyme Technologies Ltd P/E ratio currently stands at 23.82, making it one of the most tracked metrics in Advanced Enzyme Technologies Ltd Ratios.

Historically, the Advanced Enzyme Technologies Ltd P/E ratio has shown strong fluctuations:

• 2024: 23.82
• 2023: 29.16
• 2022: 24.52
• 2021: 26.39
• 2020: 26.44

The decline in Advanced Enzyme Technologies Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Advanced Enzyme Technologies Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 2.20.

Historical P/B trend:

• 2024: 2.20
• 2023: 2.93
• 2022: 2.10
• 2021: 2.90

Advanced Enzyme Technologies Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Advanced Enzyme Technologies Ltd P/S ratio currently stands at 4.91, an important part of Advanced Enzyme Technologies Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 4.91
• 2023: 6.24
• 2022: 4.79
• 2021: 5.97

A stable or declining Advanced Enzyme Technologies Ltd P/S ratio indicates cautious market sentiment.

Advanced Enzyme Technologies Ltd Price to Cash Flow Ratio (P/CF)

The Advanced Enzyme Technologies Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 20.95.

Historical Advanced Enzyme Technologies Ltd Price to Cash Flow Ratio:

• 2024: 20.95
• 2023: 25.68
• 2022: 17.76
• 2021: 25.92
• 2020: 23.76

The declining Advanced Enzyme Technologies Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Advanced Enzyme Technologies Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Advanced Enzyme Technologies Ltd EV currently stands at ₹26.18B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 26.18B
• 2023: 34.36B
• 2022: 21.9B
• 2021: 28.67B

Advanced Enzyme Technologies Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Advanced Enzyme Technologies Ltd EV/EBITDA ratio is currently 13.27, a key metric in Advanced Enzyme Technologies Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 13.27
• 2023: 16.57
• 2022: 13.30
• 2021: 13.92

Stable Advanced Enzyme Technologies Ltd EV/EBITDA indicates balanced valuation.

Advanced Enzyme Technologies Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Advanced Enzyme Technologies Ltd D/E ratio is currently 0.03, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.03
• 2023: 0.04
• 2022: 0.03
• 2021: 0.03

Advanced Enzyme Technologies Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Advanced Enzyme Technologies Ltd ROE currently stands at 9.55%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 9.55
• 2023: 10.42
• 2022: 9.09
• 2021: 11.61

Declining ROE indicates pressure on profitability.

Advanced Enzyme Technologies Ltd Ratios Analysis Summary

The Advanced Enzyme Technologies Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Advanced Enzyme Technologies Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Advanced Enzyme Technologies Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.